Marshall Wace North America L.P. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2020$566,000
-54.4%
43,441
-60.3%
0.00%
-50.0%
Q2 2020$1,241,000
-39.9%
109,440
+47.4%
0.01%
-38.5%
Q2 2019$2,064,000
+2615.8%
74,267
+3171.7%
0.01%
Q1 2019$76,000
-98.2%
2,270
-98.4%
0.00%
-100.0%
Q4 2018$4,184,000
+9.4%
143,937
+11.2%
0.04%
+110.5%
Q1 2018$3,826,000
-10.7%
129,466
+8.8%
0.02%
-29.6%
Q3 2017$4,285,000
+62.4%
119,017
-5.4%
0.03%
-51.8%
Q4 2013$2,639,000125,7990.06%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders